These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 92490)

  • 1. An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.
    Maayan ML; Volpert EM; Dawry FP
    J Endocrinol Invest; 1978 Oct; 1(4):299-304. PubMed ID: 92490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
    J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
    Kendall-Taylor P
    Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone secretion is more sensitive than thyroid cyclic AMP accumulation to stimulation with LATS in mice in vitro and in vivo.
    Ikeda H; Chiu SC; Kuzuya N; Uchimura H; Nagataki S
    J Endocrinol Invest; 1984 Feb; 7(1):1-6. PubMed ID: 6325527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of thyroidal iodothyronine 5'-monodeiodinase by long-acting thyroid stimulator (LATS).
    Wu SY; Reggio R; Florsheim W; Chopra IJ; Solomon DH
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):193-200. PubMed ID: 3825441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
    Onaya T; Kotani M; Yamada T; Ochi Y
    J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
    [No Abstract]   [Full Text] [Related]  

  • 9. Norepinephrine and thyrotropin effects on the thyroid in vitro: simultaneous stimulation of iodide organification and antagonism of thyroxine release.
    Maayan ML; Volpert EM; From A
    Endocrinology; 1981 Sep; 109(3):930-4. PubMed ID: 6167436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the radioreceptor assay of TSH: the binding of 125I-TSH to the human thyroid receptor and the interaction of LATS-IgG (author's transl)].
    Endo K
    Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1249-60. PubMed ID: 228997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of alpha 1-adrenergic receptors in the inhibitory effect of catecholamines on the thyrotropin-induced release of thyroxine by the mouse thyroid.
    Muraki T; Uzumaki H; Nakadate T; Kato R
    Endocrinology; 1982 Jan; 110(1):51-4. PubMed ID: 6274625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
    Yamashita K; Field JB
    J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 15. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
    McKenzie JM
    Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
    Holmes SD; Dirmikis SM; Martin TJ; Munro DS
    J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thyrotropin- and dibutyryl cyclic AMP-induced secretion of thyroxine and triiodothyronine by catecholamines.
    Maayan ML; Debons AF; Krimsky I; Volpert EM; From A; Dawry F; Siclari E
    Endocrinology; 1977 Jul; 101(1):284-91. PubMed ID: 193681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
    Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
    J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.